| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,411 |
16,850 |
$5.70M |
| A4649 |
Surgical supply; miscellaneous |
43,141 |
17,998 |
$3.30M |
| 0450 |
Emergency room services |
30,293 |
26,959 |
$2.84M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,134 |
1,070 |
$1.76M |
| J3490 |
Unclassified drugs |
7,382 |
5,975 |
$1.40M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,813 |
6,577 |
$846K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,892 |
8,225 |
$586K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,408 |
3,546 |
$373K |
| 36415 |
Collection of venous blood by venipuncture |
8,998 |
8,213 |
$367K |
| 71045 |
Radiologic examination, chest; single view |
13,226 |
12,447 |
$212K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,794 |
1,752 |
$185K |
| 80053 |
Comprehensive metabolic panel |
23,678 |
20,262 |
$145K |
| 0270 |
|
1,700 |
1,155 |
$121K |
| 0160 |
|
585 |
545 |
$114K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,818 |
3,709 |
$114K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,776 |
2,520 |
$111K |
| G0378 |
Hospital observation service, per hour |
743 |
640 |
$107K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,047 |
928 |
$75K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,884 |
2,792 |
$72K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
689 |
681 |
$70K |
| 81001 |
|
10,649 |
10,046 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,564 |
3,764 |
$63K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,756 |
2,591 |
$47K |
| 0250 |
|
3,282 |
1,689 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
697 |
648 |
$39K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,994 |
11,069 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,509 |
2,230 |
$34K |
| 80047 |
|
491 |
478 |
$33K |
| 85027 |
|
26,737 |
21,915 |
$30K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,095 |
2,040 |
$30K |
| 73630 |
|
698 |
690 |
$28K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,540 |
1,502 |
$28K |
| 73610 |
|
695 |
682 |
$26K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
697 |
652 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,040 |
1,936 |
$22K |
| 87077 |
|
1,562 |
1,503 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,075 |
1,058 |
$20K |
| 0272 |
|
3,089 |
2,036 |
$19K |
| 87070 |
|
272 |
254 |
$18K |
| 73562 |
|
597 |
576 |
$18K |
| 87486 |
|
1,515 |
1,479 |
$17K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
841 |
218 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,401 |
2,304 |
$17K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
438 |
131 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
475 |
463 |
$16K |
| 82077 |
|
1,055 |
990 |
$14K |
| 86850 |
|
719 |
702 |
$14K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,058 |
704 |
$14K |
| 83880 |
|
5,589 |
5,264 |
$12K |
| 87081 |
|
432 |
426 |
$12K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,988 |
1,929 |
$11K |
| 73130 |
|
360 |
354 |
$11K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,464 |
1,415 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
299 |
291 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,638 |
1,496 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,230 |
1,198 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
315 |
313 |
$8K |
| 74018 |
|
295 |
291 |
$8K |
| 84484 |
|
6,916 |
5,930 |
$8K |
| 73110 |
|
217 |
216 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,007 |
8,035 |
$7K |
| 73030 |
|
319 |
311 |
$7K |
| 87430 |
|
539 |
531 |
$6K |
| 83735 |
|
6,382 |
5,252 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,497 |
6,432 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,478 |
1,420 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,681 |
2,803 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
425 |
417 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
216 |
151 |
$5K |
| 76830 |
Ultrasound, transvaginal |
505 |
498 |
$4K |
| 85610 |
|
7,057 |
6,610 |
$4K |
| 84703 |
|
4,946 |
4,672 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
178 |
173 |
$4K |
| 83690 |
|
7,482 |
6,986 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
375 |
359 |
$4K |
| 73140 |
|
25 |
25 |
$3K |
| 72110 |
|
68 |
67 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,549 |
1,512 |
$3K |
| 87040 |
|
2,398 |
2,038 |
$3K |
| 93017 |
|
56 |
54 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,355 |
2,141 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,676 |
3,137 |
$3K |
| 70496 |
|
127 |
123 |
$3K |
| 82330 |
|
1,728 |
1,633 |
$2K |
| 0258 |
|
541 |
387 |
$2K |
| 83605 |
|
2,143 |
1,934 |
$2K |
| 87581 |
|
1,514 |
1,478 |
$2K |
| 86140 |
|
1,800 |
1,533 |
$2K |
| 93971 |
|
174 |
171 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,131 |
1,846 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,314 |
917 |
$2K |
| 85730 |
|
2,062 |
1,957 |
$2K |
| 82150 |
|
3,001 |
2,811 |
$2K |
| 87186 |
|
1,193 |
1,141 |
$1K |
| 0710 |
|
114 |
107 |
$1K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
125 |
93 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
89 |
81 |
$1K |
| 0360 |
|
26 |
14 |
$1K |
| 74019 |
|
28 |
27 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
776 |
653 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,913 |
1,466 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,786 |
1,610 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
430 |
417 |
$963.71 |
| 84702 |
|
591 |
513 |
$941.76 |
| 70498 |
|
100 |
95 |
$911.39 |
| 86900 |
|
1,254 |
1,217 |
$904.35 |
| 87252 |
|
29 |
26 |
$885.00 |
| 90715 |
|
282 |
281 |
$880.61 |
| 76801 |
|
83 |
71 |
$861.11 |
| 72170 |
|
77 |
73 |
$806.26 |
| 84100 |
|
756 |
516 |
$798.56 |
| 84145 |
|
834 |
747 |
$792.59 |
| 80329 |
|
1,055 |
974 |
$763.70 |
| 82550 |
|
535 |
478 |
$692.92 |
| 86901 |
|
1,244 |
1,207 |
$677.19 |
| 82248 |
|
1,287 |
1,204 |
$649.42 |
| 73502 |
|
14 |
14 |
$645.18 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13 |
12 |
$583.00 |
| 94729 |
|
14 |
14 |
$580.55 |
| 94726 |
|
14 |
14 |
$579.25 |
| 96376 |
|
1,425 |
960 |
$571.36 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
43 |
38 |
$499.85 |
| 93970 |
|
12 |
12 |
$452.54 |
| 80061 |
Lipid panel |
285 |
274 |
$393.79 |
| 82553 |
|
355 |
329 |
$382.58 |
| J2060 |
Injection, lorazepam, 2 mg |
747 |
595 |
$371.67 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
898 |
815 |
$354.56 |
| 85652 |
|
539 |
469 |
$328.85 |
| 85651 |
|
665 |
560 |
$297.22 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
12 |
$289.98 |
| 80320 |
|
124 |
112 |
$272.48 |
| 85379 |
|
242 |
230 |
$253.70 |
| 84439 |
|
133 |
131 |
$246.28 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
95 |
67 |
$160.30 |
| A9270 |
Non-covered item or service |
4,659 |
1,161 |
$158.17 |
| 97163 |
|
12 |
12 |
$111.57 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
85 |
76 |
$82.53 |
| 73590 |
|
26 |
25 |
$77.55 |
| J1815 |
Injection, insulin, per 5 units |
30 |
12 |
$47.31 |
| S0028 |
Injection, famotidine, 20 mg |
152 |
119 |
$46.06 |
| 83874 |
|
12 |
12 |
$30.68 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
493 |
452 |
$28.93 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
14 |
$27.06 |
| 0636 |
|
1,784 |
738 |
$15.76 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.34 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
25 |
25 |
$0.00 |